T H E R E T I N A is a thin layer of light-sensitive nerve tissue that lines the back of the eye (or vitreous) cavity. When light enters the eye, it passes through the iris to the retina where images are focused and converted to electrical impulses that are carried by the optic nerve to the brain resulting in sight.
W H AT I S T H E R E T I N A?
Symptoms and Causes: Macular edema refers to an abnormal blister of fluid in the layers of the macula. From the side, it looks like the snake that ate too much. Like a droplet of water on your computer screen, the swollen retina distorts imagesmaking it more difficult to see clearly. The more widespread, thicker, and severe the swelling becomes, the more likely one will notice visual symptoms of blur, distortion, and difficulty reading.
If untreated, chronic macular edema can lead to irreversible damage of the macula and per manent vision loss. Macular edema is typically caused by increased leakage from damaged retinal blood vessels or growth of abnormal blood vessels in the deep retina. New vessels (neovascularization or NV) do not have normal "tight junctions" and almost always result in abnormal leakage of fluid (serum from the bloodstream) into the retina. OCT is a useful test to study macular edema (ME).
• The top image is normal. Note the even layers and gently sloping dip of the macula called the fovea. This eye has excellent vision.
• The middle OCT has ME, black-appearing cysts (arrows) which threaten the normal fovea. This eye also has good vision.
• The bottom OCT shows ME involving the macula.
Because ME involves the macular center (the fovea), vision is poor (large red arrow).
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Treatment and Prognosis:
The most effective treatment strategies for macular edema address the underlying cause (diabetes, blood vessel occlusion, neovascularization, inflammation, etc), as well as an excess of fluid leaking from abnormal blood vessels in and around the macula. Eye drops, laser, and surgery can be effective in many diseases, but the mainstay of treatment is intravitreal injections (IVI). The IVI is an office procedure performed under topical anesthesia in which medication is placed inside the eye by a very small needle. The injection generally causes little to no pain. IVI should be performed by a trained retina specialist with meticulous monitoring of treatment efficacy and detection of rare but potentially serious complications. IVI is now considered one of the most commonly performed medical procedures.
Ranibizumab (Lucentis®), aflibercept (Eylea®), and dexamethasone (Ozurdex®) are the generic and trade names, respectively, of the 3 most widely used FDA-approved medications for IVI treatment of the common conditions causing macular edema.
Bevacizumab (Avastin®) is not FDA approved for this use, but has also been extensively studied in large, well-designed, federally funded clinical trials and is felt to have excellent efficacy. US physicians are permitted to use drugs in a manner not included in the FDA's approved packaging label; this common practice is known as off-label use.
Each treatment option has a considerable track record of success and works by decreasing the amount of fluid leaking from abnormal blood vessels. There are differences between each of these drugs. Your retina specialist will work with you to identify which options are best for you.
